During the past decade, Board of Regents of the University of Oklahoma conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Board of Regents of the University of Oklahoma" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator and "The Emmes Company, LLC" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Board of Regents of the University of Oklahoma" are "Heart Failure" (2 trials), "Hemophilia" (2 trials), "Hypertension" (2 trials), "Hypokalemia" (2 trials) and "Insomnia" (2 trials). Many other conditions were trialed in "Board of Regents of the University of Oklahoma" in a lesser frequency.

Most popular intervention types in "Board of Regents of the University of Oklahoma" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Lenalidomide" (1 trials), "Rituximab" (1 trials), "The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:" (1 trials) and "The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:" (1 trials). Other intervention names were less common.

The vast majority of trials in "Board of Regents of the University of Oklahoma" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Board of Regents of the University of Oklahoma". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Board of Regents of the University of Oklahoma, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Board of Regents of the University of Oklahoma, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".